Screening Tool for Early Postnatal Prediction of Retinopathy of Prematurity in Preterm Newborns (STEP-ROP)
Autor: | Caroline A. Ricard, Christiane E.L. Dammann, Olaf Dammann |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
congenital hereditary and neonatal diseases and abnormalities Pediatrics medicine.medical_specialty genetic structures Gestational Age Logistic regression Risk Assessment Severity of Illness Index Decision Support Techniques 03 medical and health sciences 0302 clinical medicine Neonatal Screening Predictive Value of Tests Pregnancy Risk Factors 030225 pediatrics medicine Odds Ratio Birth Weight Humans Screening tool Retinopathy of Prematurity Retina Respiratory Distress Syndrome Newborn Clinical screening business.industry Infant Newborn Retinopathy of prematurity Neurovascular bundle medicine.disease eye diseases medicine.anatomical_structure Early Diagnosis Logistic Models nervous system Infant Extremely Premature Pediatrics Perinatology and Child Health Multivariate Analysis 030221 ophthalmology & optometry Female sense organs Pregnancy Multiple business Developmental Biology |
Zdroj: | Neonatology. 112(2) |
ISSN: | 1661-7819 |
Popis: | Background: Retinopathy of prematurity (ROP) is a disorder of the preterm newborn characterized by neurovascular disruption in the immature retina that may cause visual impairment and blindness. Objective: To develop a clinical screening tool for early postnatal prediction of ROP in preterm newborns based on risk information available within the first 48 h of postnatal life. Methods: Using data submitted to the Vermont Oxford Network (VON) between 1995 and 2015, we created logistic regression models based on infants born Results: Of the 1,052 newborns in the VON database, 627 recorded an ROP status. Forty percent had no ROP, 40% had mild ROP (stages 1 and 2), and 20% had severe ROP (stages 3-5). We created a weighted score to predict any ROP based on the multivariable regression model. A cutoff score of 5 had the best sensitivity (95%, 95% CI 93-97), while maintaining a strong positive predictive value (63%, 95% CI 57-68). When applied to the ELGAN data, sensitivity was lower (72%, 95% CI 69-75), but PPV was higher (80%, 95% CI 77-83). Conclusions: STEP-ROP is a promising screening tool. It is easy to calculate, does not rely on extensive postnatal data collection, and can be calculated early after birth. Early ROP screening may help physicians limit patient exposure to additional risk factors, and may be useful for risk stratification in clinical trials aimed at reducing ROP. |
Databáze: | OpenAIRE |
Externí odkaz: |